These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24752835)

  • 1. Use of metformin in diseases of aging.
    Miles JM; Rule AD; Borlaug BA
    Curr Diab Rep; 2014 Jun; 14(6):490. PubMed ID: 24752835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
    Lamanna C; Monami M; Marchionni N; Mannucci E
    Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METFORMIN: NONGLYCEMIC EFFECTS AND POTENTIAL NOVEL INDICATIONS.
    Anabtawi A; Miles JM
    Endocr Pract; 2016 Aug; 22(8):999-1007. PubMed ID: 27579542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease-A Systematic Review and Meta-Analysis.
    Hu Y; Lei M; Ke G; Huang X; Peng X; Zhong L; Fu P
    Front Endocrinol (Lausanne); 2020; 11():559446. PubMed ID: 33117278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the potential benefits of metformin in patients with cardiovascular disease and heart failure.
    Norwood DK; Chilipko AA; Amin SM; Macharia D; Still KL
    Consult Pharm; 2013 Sep; 28(9):579-83. PubMed ID: 24007890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
    Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; Eckardt KU; McMurray JJV; Weinrauch LA; Liu J; Claggett B; Lewis EF; Pfeffer MA
    Diabetes Obes Metab; 2019 May; 21(5):1199-1208. PubMed ID: 30672083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
    Chiang CE; Ueng KC; Chao TH; Lin TH; Wu YJ; Wang KL; Sung SH; Yeh HI; Li YH; Liu PY; Chang KC; Shyu KG; Huang JL; Tsai CD; Hung HF; Liu ME; Chao TF; Cheng SM; Cheng HM; Chu PH; Yin WH; Wu YW; Chen WJ; Lai WT; Lin SJ; Yeh SJ; Hwang JJ
    J Chin Med Assoc; 2020 Jul; 83(7):587-621. PubMed ID: 32628427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.
    Eurich DT; Weir DL; Majumdar SR; Tsuyuki RT; Johnson JA; Tjosvold L; Vanderloo SE; McAlister FA
    Circ Heart Fail; 2013 May; 6(3):395-402. PubMed ID: 23508758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes.
    Home P
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S33-42. PubMed ID: 22650223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe Use of Metformin in Adults With Type 2 Diabetes and Chronic Kidney Disease: Lower Dosages and Sick-Day Education Are Essential.
    MacCallum L; Senior PA
    Can J Diabetes; 2019 Feb; 43(1):76-80. PubMed ID: 30061044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin in chronic kidney disease: time for a rethink.
    Heaf J
    Perit Dial Int; 2014 Jun; 34(4):353-7. PubMed ID: 24711640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.
    Rhee JJ; Han J; Montez-Rath ME; Kim SH; Cullen MR; Stafford RS; Winkelmayer WC; Chertow GM
    J Diabetes Complications; 2019 Nov; 33(11):107423. PubMed ID: 31537413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
    Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH
    Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study.
    Whitlock RH; Hougen I; Komenda P; Rigatto C; Clemens KK; Tangri N
    Mayo Clin Proc; 2020 Jan; 95(1):90-100. PubMed ID: 31902433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes.
    Rosiak M; Postula M; Kaplon-Cieslicka A; Trzepla E; Czlonkowski A; Filipiak KJ; Opolski G
    Adv Med Sci; 2013; 58(2):362-8. PubMed ID: 24327531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of combination therapy in type 2 diabetes in the post-ACCORD era.
    Kuritzky L
    Curr Diab Rep; 2012 Jun; 12(3):227-9. PubMed ID: 22528598
    [No Abstract]   [Full Text] [Related]  

  • 20. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
    Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.